Project Grant R21AI186003
Award Date
7/15/24
Completion Date
5/31/26
Dollars Obligated
$445K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43205, USA
Similar Awards
This federal Project Grant award of $246,000.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to optimize molecular polymerase chain reaction (PCR) testing for the detection of congenital syphilis. The project will determine whether PCR can detect Treponema pallidum DNA in neonates exposed to maternal syphilis and identify the best sample type and source for such PCR testing. The research...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $205,000 to The Regents of the University of California, San Francisco (UCSF) to identify novel biomarkers for the diagnosis of syphilis in pregnancy and assessment of treatment response. The key objectives are to: 1) analyze longitudinal samples from pregnant patients diagnosed with syphilis to identify novel...
This federal Project Grant award, valued at $646,814 and provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to determine the long-term risk of neurosyphilis in people with HIV who have experienced syphilis serologic nonresponse or failure following initial treatment. The award will leverage the Johns Hopkins HIV Clinical Cohort to 1) compare the incidence of symptomatic...
The University of Victoria, operating as Advancement Services, received a $260,760 Project Grant (R21AI186005) from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The purpose of this award is to develop a direct diagnostic test for infectious and congenital syphilis that exhibits high sensitivity and specificity, can differentiate active versus past infections and syphilis from yaws,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to develop a rapid diagnostic assay to improve the detection and differentiation of active versus past syphilis infections. The $698,349 award will support the creation of an integrated multiplexed diagnostic platform that can simultaneously detect treponemal and non-treponemal antibodies associated with syphilis. The...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $212,357 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Texas at Austin. The grant aims to develop a point-of-care nucleic acid test (POC NAT) for rapid, sensitive, and specific detection of syphilis in newborns and adults. Key objectives include automating the POC NAT on microfluidic devices with colorimetric readout, and evaluating the detectability of the...
The University of Washington was awarded a $188,024 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct research on local and systemic immune responses during syphilis infection. The 5-year grant, effective June 1, 2024, will support investigations into T cell antigens and antibody responses that could inform the development of a syphilis vaccine. Key objectives include...
This $264,750 project grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The grant aims to optimize methods for recovering more complete Treponema pallidum genomes from diverse clinical specimens to enable improved genomic epidemiology and syphilis outbreak response. The project will develop a tiling amplicon sequencing approach to enhance the analytical sensitivity and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,550,917 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Johns Hopkins University to develop a suite of local-level syphilis epidemiologic and economic models across 40 U.S. cities with the highest syphilis diagnosis rates. The project aims to: 1) assess the potential impact of scaling up existing syphilis control interventions such as increased testing, expanded partner tracing, and...
This $205,999 project grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate maternal-fetal immune responses against infections, including SARS-CoV-2 and malaria, during pregnancy. The award will enable the development of a cohort of young investigators to conduct high-quality translational research in the field of perinatal infectious diseases. Key objectives...